SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 152 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $462,000 | -63.2% | 29,636 | -55.2% | 0.73% | +671.6% |
| Q1 2018 | $1,256,000 | -92.1% | 66,111 | -93.2% | 0.10% | -91.8% |
| Q4 2017 | $15,844,000 | +1.4% | 966,128 | -7.2% | 1.16% | +9.4% |
| Q3 2017 | $15,622,000 | +349.7% | 1,041,478 | +163.7% | 1.06% | +320.6% |
| Q2 2017 | $3,474,000 | – | 394,877 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |